Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Embracing Vulnerability in Virtual Leadership – Building Company Culture Virtually

February 20, 2025 | DOL, HCP teams, Impetus Digital, KOL, KOL teams, MSL, Pharma leadership, Pharma trends, Remote work, company culture, hcp trends, kol trends, pharma leaders, pharma teams, virtual office, work from home 

Leadership is about more than guidance—it’s about vulnerability. Learn how being genuine and approachable can foster trust and open communication, creating a psychologically safe space for your team to thrive. Discover practical tips for implementing regular check-ins and promoting a culture of openness.

Creating a psychologically safe virtual workplace is crucial for remote team success. In the eighth video of our series on building company culture in a virtual environment, we discuss the power of vulnerability in leadership. Learn how being real and genuine can foster trust, open communication, and stronger connections within your remote team. We’ll explore practical strategies for checking in with your team asynchronously and conducting meaningful one-on-one meetings where vulnerability is encouraged.

  1. Share Vulnerability

Building trust and psychological safety is essential for high-performing remote teams. This video explores how leaders can model vulnerability to create a space where team members feel comfortable sharing their wins, challenges, and concerns. Discover how asynchronous check-ins and synchronous one-on-ones can foster open communication and strengthen team bonds.

For more insights and to learn from our experience, visit our blog: https://www.impetusdigital.com/2020/11/03/top-10-tips-for-creating-company-culture/

Enhance your virtual meeting strategies with Impetus Digital:
Check out our virtual collaboration solutions: www.impetusdigital.com
Schedule a free consultation to refine your meeting strategies: https://meetwithimpetus.com/

Stay connected for more tips on remote work and trending Pharma Topics:

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...